Geron (nasdaq: GERN - news - people), the Menlo Park, Calif.
This field is slowly gaining steam just as Geron is abandoning stem cell work.
FORBES: Stem Cell Innovator James Thomson Says Geron Blazed Trail For Others To Follow
If that future exists, it won't be Geron that will now lead the way.
Geron gern (nasdaq: gern - news - people), a Menlo Park, Calif.
Geron owns patents on and licenses the procedure to make these stem cell lines.
Geron said it was seeking partners to enable further development of its stem cell programmes.
Geron wants to inject embryonic stem cells direct into the spine of newly paralysed patients.
Geron scientists now manufacture seven different types of human cells from embryonic stem cells.
Geron, based in California, made the sudden announcement that it was halting further work in this field.
Leadoff witness Thomas Okarma, president of biotechnology company Geron Corporation, urged that current restrictions should be kept.
Geron is a company with extensive history in several leading-edge medical technologies, including human embryonic stem cells.
Geron had injected stem cells into the spine of a small number of spinal patients to test safety.
That and my other assessments of Geron from back then turn out to be almost embarrassingly credulous.
FORBES: Don't Get Too Excited About The First Embryonic Stem Cell Patient
But he says Geron has another way that the technology can make money for it in the meantime.
While preliminary findings from such companies as Geron and Nexell hold promise, the field is still in its infancy.
James Thomson, a biologist at the University of Wisconsin-Madison, turned to Geron, a biotech firm in Menlo Park, Calif.
One of the first products that we created in collaboration with Geron was cardiomyocyte generation from h7 hES cells.
Colao, Dolia Estevez, Daniel Fisher, Agustino Fontevecchia, Tomio Geron, Jenna Goudreau, Lisa H.
FORBES: Inside The 2013 Billionaires List: Facts and Figures
Geron's next application will be for a stem cell treatment for heart failure.
In the new issue of Forbes, Tomio Geron writes about the unstoppable rise of the share economy.
FORBES: Beyond The Auto Industry's Secret Fear: The Share Economy
We'd like to highlight four companies with unique approaches to stem cell therapies: Cytori Therapeutics, Geron, Athersys and Celgene.
Memphis' Geron Johnson scored 13 of his 16 points in the first half, and Joe Jackson finished with 12 points.
Now the first clinical trial of embryonic stem cells, by Geron of Menlo Park California, has started after years of delay.
Geron will retain rights of its most advanced telomerase vaccine, with an option for Merck to buy it in the future.
Geron, it seems, may now have the capacity to do exactly that.
This is true whether they use so-called adult stem cells, as Osiris Therapeutics and Cytori do, or the embryonic kind, like Geron.
Geron's drug aims to fix them so the tumors expire on schedule.
Geron's treatment for spinal cord injury was the first human embryonic stem cell therapy to receive FDA approval for a clinical trial.
Pain Therapeutics fell 18%, artificial heart maker Abiomed fell 17%, Keryx fell 13%, Geron fell 11%, and antidepressant maker Clinical Data fell 10%.
The trials are not expected to start until summer, because many of the preparations could not begin until Geron had FDA approval, Okarma said.
应用推荐